LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
Status:
Not yet recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This multicenter trial is being conducted to determine if sequential lactulose and Tele
(virtual) Tai-Chi reduces the rate of injurious fall, non-injurious falls, incident overt
Hepatic Encephalopathy (HE), and death.
Participants that are enrolled will be randomized to stage one of this project for
approximately 12 weeks. After completing stage one, participants will be re-evaluated and if
eligible will be re-randomized to stage 2 of the project that will last approximately 12 more
weeks.
The study hypothesizes that sequential lactulose/TeleTai-Chi will reduce falls, incident
overt HE, death and physical frailty and will improve cognitive function, and Health Related
Quality of Life (HRQOL) over 24 weeks compared to other treatment combinations.